Canaccord Genuity reiterates a 'Buy' on Sunesis Pharmaceuticals (SNSS); Attractive Risk/Reward Ahead of Results
Tweet
Share
E-mailGet Alerts SNSS Hot Sheet
Price: $5.32 --0%
Rating Summary:
5 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS) price target of $4.00.
Analyst, George Farmer, said, "We reiterate our rating on our view of an attractive risk/reward ahead of results from the Phase III VALOR trial evaluating lead oncology drug candidate vosaroxin for treatment of acute myelogenous leukemia (AML)."
"SNSS reported YE11 cash of $44M, which, along with credit line proceeds, should be sufficient through final Phase III read-out in mid-2013/early-2014 without/with trial expansion. This guidance is in line with our $31M YE12 cash burn estimate."
For an analyst ratings summary and ratings history on Sunesis Pharmaceuticals Inc. click here. For more ratings news on Sunesis Pharmaceuticals Inc. click here.
Shares of Sunesis Pharmaceuticals Inc. closed at $2.46 yesterday.
Analyst, George Farmer, said, "We reiterate our rating on our view of an attractive risk/reward ahead of results from the Phase III VALOR trial evaluating lead oncology drug candidate vosaroxin for treatment of acute myelogenous leukemia (AML)."
"SNSS reported YE11 cash of $44M, which, along with credit line proceeds, should be sufficient through final Phase III read-out in mid-2013/early-2014 without/with trial expansion. This guidance is in line with our $31M YE12 cash burn estimate."
For an analyst ratings summary and ratings history on Sunesis Pharmaceuticals Inc. click here. For more ratings news on Sunesis Pharmaceuticals Inc. click here.
Shares of Sunesis Pharmaceuticals Inc. closed at $2.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
